IX vs RGLD vs RPRX Stock Comparison

Orix, Royal Gold and Royalty Pharma Prices as of Nov 13, 2026 Peers: Industry group
IX Orix Corp
$34.39 -5.7% 1M +32.1% 1Y
Market cap
$37.58B
P/E
5.8x
Revenue (TTM)
$41.73B
Div. yield
–
Specialty Finance Financial Services
3 wins
RGLD Royal Gold Inc
$256.89 +14.3% 1M +35.6% 1Y
Market cap
$21.07B
P/E
25.1x
Revenue (TTM)
$1.76B
Div. yield
0.01%
Specialty Finance Financial Services
5 wins
RPRX Royalty Pharma plc
$69.31 +17.5% 1M +74.5% 1Y
Market cap
$30.51B
P/E
45.4x
Revenue (TTM)
$2.62B
Div. yield
–
Specialty Finance Financial Services
2 wins

Head to Head

10 decided of 12

Royal Gold leads on 5 of the 12 questions below (Royal Gold 5, Orix 3, Royalty Pharma 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionIXRGLDRPRXLeader
Larger companyMarket capitalisation $37.58B $21.07B $30.51B IX
Cheaper on earningsLower P/E, profitable companies only 5.8x 25.1x 45.4x IX
Cheaper on forward earningsLower price / next fiscal year consensus EPS 7.9x 22.9x 12.2x IX
Faster revenue growthRevenue growth, trailing twelve months -23.5% +105.2% +11.4% RGLD
More profitableNet margin, trailing twelve months 15.6% 47.7% 25.7% RGLD
Better return on capitalReturn on invested capital 2.8% 11.1% — RGLD
Less leveragedLower net debt / EBITDA — 0.0x — –
Higher dividend yieldTrailing dividend yield 0.00% 0.01% 0.00% –
Better 1-year returnPrice return, last 12 months +32.1% +35.6% +74.5% RPRX
Better 5-year returnAnnualised price return, 5 years +10.6%/yr +19.2%/yr +10.6%/yr RGLD
Less volatileAnnualised volatility, 1 year 29.0% 42.3% 22.1% RPRX
Higher overall scoreMean of the five percentile scores vs peers 60/100 77/100 54/100 RGLD

Percentile Scorecard

IXRGLDRPRX

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisIXRGLDRPRX
Valuation 78 #39 of 173 25 #130 of 173 17 #143 of 173
Growth 81 #33 of 169 97 #6 of 169 76 #42 of 169
Profitability 79 #34 of 156 97 #5 of 156 95 #9 of 156
Financial Health 57 #71 of 164 97 #6 of 164 72 #46 of 164
Shareholder Returns 5 #129 of 136 70 #42 of 136 10 #123 of 136
Overall 60 77 54
  • IX ranked among 176 companies in Lending and Credit
  • RGLD ranked among 176 companies in Lending and Credit
  • RPRX ranked among 176 companies in Lending and Credit

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodIXRGLDRPRXSPY
1 month -5.7%+14.3%+17.5% -2.0%
3 months -14.3%+11.4%+18.3% -2.8%
6 months -6.2%+12.5%+31.1% +2.0%
Year to date +17.7%+15.6%+79.4% +10.6%
1 year +32.1%+35.6%+74.5% +12.2%
3 years +90.2%+132.1%+151.9% +68.1%
3 years, per year +23.9%+32.4%+36.1% +18.9%
5 years +65.3%+140.7%+65.3% +61.4%
5 years, per year +10.6%+19.2%+10.6% +10.1%
10 years +113.9%+292.3%— +248.5%
10 years, per year +7.9%+14.6%— +13.3%

Risk

MeasureIXRGLDRPRXSPY
Volatility, 1Y 29.0%42.3%22.1% 13.6%
Downside volatility, 1Y 29.0%42.3%21.0% 13.9%
Beta vs S&P 500, 1Y 0.941.210.23 1.00
Return / volatility, 1Y 1.100.843.36 0.90
Max drawdown, 5Y -39.0%-40.9%-45.6% -25.4%
From 52-week high -16.8%-15.6%-1.0% -3.2%
52-week high $41.31$304.29$70.01 $779.14
52-week low $25.42$183.79$38.09 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleIXRGLDRPRX
P/E now vs peer median 5.9xmedian 11.6x 25.9xmedian 11.6x 46.0xmedian 11.6x
P/S now vs peer median 0.9xmedian 2.5x 12.3xmedian 2.5x 15.2xmedian 2.5x
EV/EBITDA now vs peer median —median 9.5x 15.0xmedian 9.5x —median 9.5x
P/FCF now vs peer median —median 4.7x 18.7xmedian 4.7x 13.4xmedian 4.7x
P/B now vs peer median 1.2xmedian 0.7x 2.8xmedian 0.7x 4.1xmedian 0.7x
PEG now vs peer median 0.12median 0.32 0.64median 0.32 0.79median 0.32

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsIXRGLDRPRX
Revenue $41.73B $1.76B $2.62B
Gross profit $38.64B $1.53B –
Operating income $2.96B $1.09B $1.50B
Net income $6.59B $841.08M $1.17B
Free cash flow – $1.16B $2.96B
R&D – – $251.40M
EPS (diluted) $5.82 $9.88 $1.21
Cash & equivalents $7.17B $184.54M $513.66M
Total debt $38.77B $146.15M $8.59B
Shares (diluted) 1.12B 84.89M 557.00M
Enterprise value $9.72B $20.23B $27.88B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricIXRGLDRPRX
P/E 5.9x 25.9x 46.0x
P/FCF – 18.7x 13.4x
P/Operating cash flow – 17.9x 13.4x
P/S 0.9x 12.3x 15.2x
P/B 1.2x 2.8x 4.1x
P/Tangible book 1.2x 2.8x 4.1x
EV/EBITDA – 15.0x –
EV/EBIT 24.4x 19.8x 32.0x
EV/Revenue 1.7x 12.3x 18.3x
EV/FCF – 18.6x 16.2x
EV/Operating cash flow – 17.8x 16.2x
PEG (3Y EPS CAGR) 0.12 0.64 0.79

Growth

14 metrics
MetricIXRGLDRPRX
Revenue growth (1Y) -23.5% 105.2% 11.4%
Revenue CAGR (3Y) -3.2% 41.9% 4.0%
Gross profit growth (1Y) 2,245% 102.6% –
Gross profit CAGR (3Y) 7.8% 57.3% –
Operating income growth (1Y) 12.9% 94.7% -2.4%
Operating income CAGR (3Y) 4.5% 54.3% 55.6%
Net income growth (1Y) 120.4% 73.3% -9.9%
Net income CAGR (3Y) 44.7% 53.3% 46.6%
EPS growth (1Y) 124.9% 35.5% -11.6%
EPS CAGR (3Y) 47.6% 40.7% 57.9%
Operating cash flow growth (1Y) – 101.1% 23.1%
Operating cash flow CAGR (3Y) – 43.0% 2.0%
Free cash flow growth (1Y) – 291.6% 23.1%
Free cash flow CAGR (3Y) – 77.9% 2.0%

Profitability

14 metrics
MetricIXRGLDRPRX
Gross margin 63.8% 86.7% –
EBITDA margin – 81.9% –
Operating margin 6.9% 62.0% 57.1%
Pretax margin 21.5% 58.8% 44.8%
Net margin 15.6% 47.7% 25.7%
FCF margin – 66.1% 113.1%
Operating cash flow margin – 69.0% 113.1%
Return on equity 21.1% 10.9% 12.0%
Return on assets 6.2% 8.9% 6.0%
Return on invested capital 2.8% 11.1% –
Return on capital employed – 11.8% 8.1%
Asset turnover 0.4x 0.2x 0.1x
Cash conversion (OCF / net income) – 1.4x 2.5x
Stock comp / revenue – 0.7% –

Financial Health

11 metrics
MetricIXRGLDRPRX
Debt / assets 39.1% 1.6% 44.1%
Debt / equity 1.2x 0.0x 0.9x
Net debt / EBITDA – 0.0x –
Debt / FCF – 0.1x 2.9x
Liabilities / assets 66.9% 17.0% 49.7%
Equity / assets 33.1% 83.0% 50.3%
Interest coverage 2.4x 23.7x 4.0x
Current ratio – 2.4x 1.3x
Quick ratio – 2.0x 0.5x
Cash ratio – 1.1x 0.5x
Altman Z-score – 9.08 3.06

Shareholder Returns

7 metrics
MetricIXRGLDRPRX
Dividend yield 1.1% 0.7% 1.6%
Net buyback yield -3.5% 0.0% –
Shareholder yield -2.3% 0.8% 1.6%
Payout ratio (earnings) – 17.9% –
Payout ratio (FCF) – 12.9% –
Dividend growth (1Y) – 30.6% –
Dividend CAGR (3Y) – 15.8% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusIXRGLDRPRX
Forward P/E 7.9xFY2026 22.9xFY2026 12.2xFY2026
EPS, next fiscal year $4.36FY2026 $11.20FY2026 $5.69FY2026
EPS growth, next FY +71.7%FY2026 +52.8%FY2026 +17.8%FY2026
EPS growth, the year after -24.3% +21.0% +9.5%
Revenue, next fiscal year $22.52BFY2026 $1.94BFY2026 $3.78BFY2026
Revenue growth, next FY +6.6%FY2026 +88.4%FY2026 +16.3%FY2026
Revenue growth, the year after -2.1% +4.2% +7.8%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersIXRGLDRPRX
Held by institutions 3.3% 83.5% 82.2%
Institutions holding 320 764 643
Change in shares held, QoQ +9.5% +1.2% +2.7%
Institutions buying 211 379 395
Institutions selling 57 265 179
Buyers to sellers 3.70 1.43 2.21

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

IXRGLDRPRX
IX 1.00 0.32 0.14
RGLD 0.32 1.00 0.16
RPRX 0.14 0.16 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, IX, RGLD and RPRX?

Orix (IX) is the largest by market capitalisation: Orix (IX) $37.58B, Royal Gold (RGLD) $21.07B, Royalty Pharma (RPRX) $30.51B.

Which stock is cheaper, IX, RGLD and RPRX?

Orix (IX) trades on the lowest price-to-earnings ratio (Orix (IX) 5.8x, Royal Gold (RGLD) 25.1x, Royalty Pharma (RPRX) 45.4x). On next year's consensus earnings, Orix (IX) is cheapest (Orix (IX) 7.9x, Royal Gold (RGLD) 22.9x, Royalty Pharma (RPRX) 12.2x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Royal Gold (RGLD) grew revenue fastest over the trailing twelve months: Orix (IX) -23.5%, Royal Gold (RGLD) +105.2%, Royalty Pharma (RPRX) +11.4%.

Which company is more profitable?

Royal Gold (RGLD) has the highest net margin (Orix (IX) 15.6%, Royal Gold (RGLD) 47.7%, Royalty Pharma (RPRX) 25.7%). On return on invested capital, Royal Gold (RGLD) leads (Orix (IX) 2.8%, Royal Gold (RGLD) 11.1%).

Which stock has performed better?

Over the past year Royalty Pharma (RPRX) returned the most: Orix (IX) +32.1%, Royal Gold (RGLD) +35.6%, Royalty Pharma (RPRX) +74.5%. Over five years, Royal Gold (RGLD) compounded fastest (Orix (IX) +10.6%/yr, Royal Gold (RGLD) +19.2%/yr, Royalty Pharma (RPRX) +10.6%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Orix (IX) 0.00%, Royal Gold (RGLD) 0.01%, Royalty Pharma (RPRX) 0.00%. Orix (IX) and Royalty Pharma (RPRX) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Royalty Pharma (RPRX) has been the steadiest (Orix (IX) 29.0%, Royal Gold (RGLD) 42.3%, Royalty Pharma (RPRX) 22.1%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, IX, RGLD and RPRX?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Royal Gold (RGLD) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.